Population pharmacokinetics of intraperitoneal irinotecan and SN-38 in patients with peritoneal metastases from colorectal origin.

MLA

Rietveld, Pascale C. S., et al. “Population Pharmacokinetics of Intraperitoneal Irinotecan and SN-38 in Patients with Peritoneal Metastases from Colorectal Origin.” CPT: Pharmacometrics & Systems Pharmacology, vol. 13, no. 6, June 2024, pp. 1006–16. EBSCOhost, https://doi.org/10.1002/psp4.13136.

APA

Rietveld, P. C. S., Sassen, S. D. T., Guchelaar, N. A. D., van Eerden, R. A. G., de Boer, N. L., van den Heuvel, T. B. M., Burger, J. W. A., Mathijssen, R. H. J., Koch, B. C. P., & Koolen, S. L. W. (2024). Population pharmacokinetics of intraperitoneal irinotecan and SN-38 in patients with peritoneal metastases from colorectal origin. CPT: Pharmacometrics & Systems Pharmacology, 13(6), 1006–1016. https://doi.org/10.1002/psp4.13136

Chicago

Rietveld, Pascale C S, Sebastiaan D T Sassen, Niels A D Guchelaar, Ruben A G van Eerden, Nadine L de Boer, Teun B M van den Heuvel, Jacobus W A Burger, Ron H J Mathijssen, Birgit C P Koch, and Stijn L W Koolen. 2024. “Population Pharmacokinetics of Intraperitoneal Irinotecan and SN-38 in Patients with Peritoneal Metastases from Colorectal Origin.” CPT: Pharmacometrics & Systems Pharmacology 13 (6): 1006–16. doi:10.1002/psp4.13136.